Skip Navigation

  1. About Us
    1. Overview
    2. History
    3. Recognition
    4. Offices
  2. Our Practice
    1. Practice Areas
      1. Patents, Utility Models, and Industrial Designs
      2. Trademarks
      3. Copyrights
      4. Corporate, Commercial and Business Law
      5. IP Litigation, Alternative Dispute Resolution
      6. Regulatory Law
      7. Licensing, Tech Transfer & Franchising
      8. Anti-Piracy, Anti-Counterfeiting & Enforcement
    2. Industry Groups
      1. Media, Sports & Entertainment Law Group
      2. Life Science & Pharmaceutical Law Group
  3. Our People
    1. Partners
      1. Sergio L. Olivares, Sr. † (1931-2010)
      2. Sergio L. Olivares, Jr.
      3. Luis C. Schmidt
      4. Cesar Ramos, Jr.
      5. Antonio Belaunzarán
      6. Gustavo A. Alcocer
      7. Alejandro Luna
      8. Alonso Camargo
      9. Daniel Sanchez
    2. Associates (A - M)
      1. Osvaldo Amaral
      2. Armando Arenas
      3. Sofía Arroyo
      4. Guillermo Ballesteros
      5. Abraham Diaz
      6. Georgina Flores
      7. Pedro Herrera
    3. Associates (N - Z)
      1. Mauricio Narváez
      2. Víctor Ramírez
      3. Sergio Rangel
      4. Maria del Carmen Sada
      5. Juan Luis Serrano
      6. Guillermo Treviño
    4. Attorneys / Engineers
      1. Emilio Albarrán
      2. Agustín Azcatl
      3. Alejandra Badillo
      4. Ignacio Burgoa
      5. Fernando Calderón
      6. Martha Celis
      7. Erwin Cruz
      8. Fernanda Díaz
      9. Luz Elena Elías
      10. Maria Fenton
      11. 12 more items...
    5. Firm Administration
    6. Directory
  4. Knowledge & Resources
    1. Articles
      1. Trademark Law Articles
        1. International Comparative Legal Guide: Trademarks 2013
        2. Altering the distinctive sign of a mark
        3. Filing reforms will save paper and money
        4. Getting the Deal Through -Trademarks 2013
        5. A new solution for trade mark filing errors
        6. Crossed wires: protecting medicines in Mexico
        7. New Trademark Examiner's Manual
        8. Supreme Court: individuals can register marks
        9. Use requirements
        10. Approach to composite marks changed, again
        11. 50 more items...
      2. Patent Law Articles
        1. PPH programmes in Mexico
        2. Patents rejected for lack of proof
        3. When copyrights and patents collide
        4. Design protection can be broadened
        5. Maximising IP rights in the life sciences industry
        6. Life Sciences - Multi-jurisdictional Guide 2012: Mexico
        7. Getting the Deal Through - Patents 2012
        8. Surge of Patent Application Final Rejections Provides Unique Opportunity for Patent Precent Making
        9. Mexico issues regulations to approve biologic drugs
        10. Latin America Roundtable
        11. 43 more items...
      3. Copyright Law Articles
        1. When copyrights and patents collide
        2. The first balanced approach to protecting copyright online
        3. How to prevent frivolous actions
        4. Advertising in social media networks
        5. Technology challenges digital rights
        6. Exceptions to copyright protection and the permitted uses of copyright works in the hi-tech and digital sectors
        7. Derechos sobre producción audiovisual
        8. How Latin America tackles cutting-edge IP issues
        9. Copyright Litigation 2010
        10. Legislation and enforcement - Copyrights 2010
        11. 103 more items...
      4. Corporate Law Articles
        1. The International Comparative Legal Guide to: Merger Control 2012
        2. Mexico issues Personal Data Protection Rules
        3. How data affects innovation
        4. A practical cross-border
        5. New registry for security interests
        6. The International Comparative Legal Guide to: Merger Control 2011
        7. The International Comparative Legal Guide to: Merger Control 2010
        8. Due diligence issues to consider in M&A
        9. Income expectations in licensing
        10. The reasons for valuation
        11. 1 more item...
      5. IP Litigation, ADR Articles
        1. Scope of new specialised courts widened
        2. Reform of preliminary injunctions
        3. Mexican Patent Office excludes Formulation Patents from Linkage Gazette
        4. Mexico gets ready to approve biocomparable drugs
        5. Mexico's hotel for the stars highlights power in the name
        6. Supreme Court upholds the worth of formulation patents
        7. Getting the Deal Through - Patents 2010
        8. Getting the Deal Through Trademarks 2010
        9. Trademark enforcement
        10. Venues for appealing IMPI decisions
        11. 15 more items...
      6. Regulatory Law Articles
        1. Life Sciences - Multi-jurisdictional Guide 2012: Mexico
        2. Maximising IP rights in the life sciences industry
        3. Recent amendment to the Federal Law for Consumer Protection
        4. Amendments to the Federal Law for Consumer Protection
        5. Mexico issues Personal Data Protection Rules
        6. New Regulations Pending
        7. Marketing authorization for pharmaceutical products to foreign applicants
        8. Data Package Exclusivity (DPE)
        9. Supreme Court upholds the worth of formulation patents
        10. Pharmaceutical trademarks
        11. 6 more items...
      7. Licensing, Tech Transfer Articles
        1. Creating a secure franchise system
      8. Anti-Piracy, Anti-Counterfeiting Articles
        1. New register against counterfeits
        2. Beat the counterfeiters in Mexico
        3. Battling counterfeits through Customs
        4. Getting the Deal Through Trademarks 2010
        5. Enforcing plant variety rights in Mexico
        6. Pharmaceutical Trademarks 2009
        7. Internet Issues
        8. Anti-counterfeiting 2009
        9. Vegetal variety rights enforced
        10. New Customs rules lead to seizures
        11. 3 more items...
      9. Media, Sports & Entertainment Focused Articles
        1. Advertising in social media networks
        2. Whither Rental Rights?
        3. Improved protection for personalities
      10. Life Sciences Focused Articles
        1. Crossed wires: protecting medicines in Mexico
        2. Current Conditions of Use Claims in the Pharmaceutical Sector in Mexico
        3. Maximising IP rights in the life sciences industry
        4. Life Sciences - Multi-jurisdictional Guide 2012: Mexico
        5. Latin America Roundtable
        6. New regulations pending
        7. The International Comparative
        8. Approval of follow-on biologics in Mexico
        9. Global Pharmaceutical Linkage Regulations:
        10. Life Sciences Handbook 2011 - Country Q&A
        11. 5 more items...
      11. 2 more items...
    2. Webinar Archive
      1. Webinar - Changes to Mexican Patent and Healthcare Laws for Life Sciences
      2. Webinar - Digital Rights Issues in Copyright Law
      3. Webinar - Data Package Exclusivity Rights in Latin America
    3. Recognition
    4. News
      1. Mexico's adhesion to the Madrid Protocol
      2. Intellectual Property: Past & Future
      3. Bill to diminish the life term of patents for medicaments
      4. Alejandro Luna's interview "La innovación
      5. Formulation patents included in the Linkage Gazette for the first time
      6. Mexico has signed the Anti-Counterfeiting Trade Agreement (ACTA)
      7. Mexican patent office shows intention to follow the Jurisprudence by which the Mexican Supreme Court gives clarification on how the Linkage Regulation applies to formulation patents
      8. Mexico moves forward for the recognition of Data Packaging Exclusivity in Mexico
      9. Olivares & Cía. named Mexico's Firm of the Year 2012 - Copyright
      10. Mexico subscribes Madrid Protocol
      11. 12 more items...
    5. Gazettes
      1. Mexican Linkage Gazette March 2013
      2. Mexican Linkage Gazette December 2012
      3. Mexican Linkage Gazette November 2012
      4. Mexican Linkage Gazette December 2011
      5. Mexican Linkage Gazette April 2011
      6. Mexican Linkage Gazette Aug 2010
      7. Mexican Linkage Gazette Dec 2009
  5. Events
  6. Offices
  7. Contact Us
  8. Quick guide to Mexico’s regulatory system
    1. Patent regulatory overview
    2. Trademark regulatory overview
    3. Copyright regulatory overview
    4. Corporate & Commercial Regulatory overview

Home » English » Knowledge & Resources » News » Mexican patent office shows intention to follow the Jurisprudence by which the Mexican Supreme Court gives clarification on how the Linkage Regulation applies to formulation patents

Mexican patent office shows intention to follow the Jurisprudence by which the Mexican Supreme Court gives clarification on how the Linkage Regulation applies to formulation patents

On July 6th, 2012 as done every six months, IMPI circulated a draft of the next edition of the Linkage Gazette, which is expected to be published by the end of this month.

In previous newsletters that can be found at www.olivares.com.mx, we have reported the developments of the Linkage regulation in Mexico since 2003, date of its enactment until the issuance of the jurisprudence in 2010 by the Mexican Supreme Court interpreting the scope of the Linkage regulation. In this regard we have highlighted that after more than fifty favorable decisions obtained by our law firm ordering the inclusion of formulation and use patents, the cases reached the Supreme Court to solve the dilemma as whether or not formulation patents should be included in the Linkage Gazette, the Supreme Court ruled that they should be included.

Two years after the jurisprudence, IMPI as administrative authority was reluctant to follow the Supreme Court Jurisprudence which is only binding to Courts of Law, therefore patent holders have required to litigate in order to obtain the benefits of the jurisprudence.

In this test draft of the Linkage Gazette, according to the Mexican Supreme Court Jurisprudence, there is a chapter at the end listing seven formulation patents (four owned by local companies and three by foreign companies) without litigation.

Therefore it seems that IMPI is willing to include the formulation patents and follow the jurisprudence, however we are unsure whether this draft will prevail in the ongoing discussions between the R&D and generic chambers, and what the process for further inclusions will be and if use patents will be also included.

We will follow up closely and keep our clients updated on this matter.